05/06/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 6:05 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
04/18/2024 6:00 AM | RedHill Biopharma (Filer)
| Form POS AM | |
04/08/2024 8:25 AM | RedHill Biopharma (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/08/2024 8:28 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 3:05 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/03/2024 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 3:38 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024 7:54 AM | RedHill Biopharma (Filer)
| Form 424B3 | |
02/15/2024 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
02/09/2024 3:20 PM | RedHill Biopharma (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
02/05/2024 7:00 AM | RedHill Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/01/2024 9:22 AM | CVI Investments, Inc. (Filed by) RedHill Biopharma (Subject)
| Form SC 13G | |
01/26/2024 11:50 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/26/2024 8:29 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
01/26/2024 8:31 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024 8:09 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024 5:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 9:23 AM | Empery Asset Management, LP (Filed by) RedHill Biopharma (Subject)
| Form SC 13G/A | |
01/02/2024 3:26 PM | RedHill Biopharma (Subject) SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/20/2023 7:45 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023 3:10 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023 11:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
10/26/2023 3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
10/23/2023 3:06 PM | RedHill Biopharma (Filer)
| Form F-3/A | |
10/16/2023 3:05 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/13/2023 7:13 AM | RedHill Biopharma (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
10/12/2023 3:05 PM | RedHill Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/10/2023 8:08 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023 7:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
weirdest stock market marches on (Ad) For the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth.
And he sure seems to be right!
Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs.
That’s why this headline called it the “Weirdest bull market” Graham is hosting a “tell all” workshop about his Apex Indicator here |
09/22/2023 3:17 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/17/2023 6:07 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2023 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
08/11/2023 3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
08/09/2023 8:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2023 8:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023 6:04 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023 12:31 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023 12:33 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023 11:09 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023 7:00 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
07/21/2023 8:37 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/21/2023 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023 6:10 AM | RedHill Biopharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/12/2023 7:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2023 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |